Patents by Inventor Mandy BOONTANRART

Mandy BOONTANRART has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-MFI2 antibodies and methods of use
    Patent number: 10428156
    Abstract: Provided are novel anti-MFI2 antibodies and antibody drug conjugates, and methods of using such anti-MFI2 antibodies and antibody drug conjugates to treat cancer.
    Type: Grant
    Filed: September 4, 2015
    Date of Patent: October 1, 2019
    Assignee: Abbvie Stemcentrx LLC
    Inventors: Samuel Williams, Laura Saunders, Holger Karsunky, Mandy Boontanrart
  • NOVEL ANTI-TNFRSF21 ANTIBODIES AND METHODS OF USE
    Publication number: 20190127476
    Abstract: Provided are novel anti-TNFRSF21 antibodies and antibody drug conjugates, and methods of using such anti-TNFRSF21 antibodies and antibody drug conjugates to treat cancer.
    Type: Application
    Filed: May 5, 2017
    Publication date: May 2, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: LAURA SAUNDERS, DEEPTI ROKKAM, DAVID LIU, MANDY BOONTANRART, ALEXANDER JOHN BANKOVICH, EVAN BISHOP, MONETTE AUJAY, ZHAO HUANG
  • Anti-DPEP3 antibodies and methods of use
    Patent number: 10189910
    Abstract: Provided herein are novel anti-DPEP3 antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
    Type: Grant
    Filed: June 13, 2016
    Date of Patent: January 29, 2019
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Laura Saunders, Deepti Rokkam, David Liu, Mandy Boontanrart
  • NOVEL ANTI-MFI2 ANTIBODIES AND METHODS OF USE
    Publication number: 20170320960
    Abstract: Provided are novel anti-MFI2 antibodies and antibody drug conjugates, and methods of using such anti-MFI2 anti-bodies and antibody drug conjugates to treat cancer.
    Type: Application
    Filed: September 4, 2015
    Publication date: November 9, 2017
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: SAMUEL WILLIAMS, LAURA SAUNDERS, HOLGER KARSUNKY, MANDY BOONTANRART
  • Anti-DPEP3 antibodies and methods of use
    Patent number: 9777071
    Abstract: Provided herein are novel anti-DPEP3 antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: October 3, 2017
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Laura Saunders, Deepti Rokkam, David Liu, Mandy Boontanrart
  • NOVEL ANTI-RNF43 ANTIBODIES AND METHODS OF USE
    Publication number: 20170073430
    Abstract: The invention discloses novel anti-RNF43 antibodies and derivatives thereof, including antibody drug conjugates, and methods of using such anti-RNF43 antibodies and antibody drug conjugates to diagnose and treat cancer.
    Type: Application
    Filed: April 21, 2015
    Publication date: March 16, 2017
    Applicant: AbbVie Stemcentrx LLC
    Inventors: MANDY BOONTANRART, DEEPTI ROKKAM, DAVID LIU, SCOTT J. DYLLA, MONETTE AUJAY
  • NOVEL ANTI-DPEP3 ANTIBODIES AND METHODS OF USE
    Publication number: 20170044271
    Abstract: Provided herein are novel anti-DPEP3 antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
    Type: Application
    Filed: October 21, 2016
    Publication date: February 16, 2017
    Applicant: AbbVie Stemcentrx LLC
    Inventors: LAURA SAUNDERS, DEEPTI ROKKAM, DAVID LIU, MANDY BOONTANRART
  • NOVEL ANTI-DPEP3 ANTIBODIES AND METHODS OF USE
    Publication number: 20170029530
    Abstract: Provided herein are novel anti-DPEP3 antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
    Type: Application
    Filed: June 13, 2016
    Publication date: February 2, 2017
    Applicant: AbbVie Stemcentrx LLC
    Inventors: Laura SAUNDERS, Deepti ROKKAM, David LIU, Mandy BOONTANRART